Clinical Trials Arena July 4, 2024
The company has added two university sites in California and Utah.
A day after hitting its paediatric enrolment goal, Spectral AI has widened the reach of its pivotal burn study by adding two clinical trial sites in the US.
The addition of the University of California San Diego and the University of Utah brings the total number of US clinical trial sites to 14.
The pivotal study (NCT06131203) is evaluating the US company’s AI wound diagnostics platform DeepView.
Spectral AI’s CEO Peter Carlson said: “These two new sites allow us to capture additional burn patients who enter through the emergency department and thus complement our existing trial site presence at burn centres across the country, establish our presence in new...
Today's Sponsors
Today's Sponsor